Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Electroporation for Basal Cell Carcinomas
NCT05046262Phase 3Unknown
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Jan 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcium chloride in basal cell carcinoma (BCC), sponsored by Bispebjerg and Frederiksberg Hospital. Status: unknown.
02
Drugs
calcium chloride
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT05046262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05046262.